Radiant Sage expands service offering in Europe

Radiant Sage expands service offering in Europe
Register for free to listen to this article
Listen with Speechify
0:00
2:00
BELMONT, Mass. & OSLO, Norway—In February, Radiant Sage LLC, a provider of on-demand clinical trial imaging infrastructure solutions and services, announced that it has expanded its operations into Europe through its partnership with Clearpoint Image Review Center (CIRC). Based in Oslo, Norway, CIRC is an imaging contract research organization (CRO) that provides sponsors with extensive medical, operational and image management expertise in support of clinical trials.
Continue reading below...
Illustration of diverse healthcare professionals interacting with digital medical data and health records on virtual screens.
WebinarsAccelerating rare disease clinical trials
Explore how a rare kidney disease trial achieved faster patient enrollment with data-informed strategies and collaborative partnerships.
Read More
CIRC will provide the facility and staffing resources for program management-based support for clinical studies in both the European Union and the United States. They will also offer a wide range of services, including audit support, document development and reader logistics to clinical study sponsor communications, site support and metrics reporting. In addition, CIRC will be able to leverage Radiant Sage's technology, staff and resources to support clients' clinical research studies.
Jeffrey Bowden, Radiant Sage’s chief operating officer explained: “This teaming partnership represents an evolution in the industry, which is being driven by both advances in technology and the needs of clinical trial sponsors. Products like our Corelab-In-A-Box are virtually eliminating the need to have large laboratories of expensive imaging technology centrally maintained to process images and organize data for blinded reads. Now, trial sponsors can make much better use of regionally defined experts in a similar approach to that used in the CRO industry where medical monitors, program managers and clinical research associates are now decentralized and regionally located, providing a higher level of service to sponsors and clinical sites. The same can be done within the core lab industry, which is why this partnership with CIRC is an evolutionary step and will provide clinical trial sponsors with superior services, expertise and experience.”
Continue reading below...
A scientist wearing gloves handles a pipette over a petri dish and a color-coded microplate in a laboratory setting.
Application NoteThe unsung tools behind analytical testing success
Learn how fundamental laboratory tools like pipettes and balances support analytical precision.
Read More
“Our clients are located throughout the world, and having a partner in Europe will help us to better serve clinical trial sponsors with exceptionally experienced and regionally located staffing,” said Venkatesan Thangaraj, Radiant Sage’s CEO. “This partnership is a win-win for both companies, as well as our clients. We have complementary services and enable each other to expand our geographic footprints.”

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
3D illustration showing a DNA double helix encapsulated in a transparent capsule, surrounded by abstract white and orange protein-like molecular structures against a blue background.
Discover an integrated analytical approach that unites identification, purification, and stability assessment for therapeutic molecules.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue